Cargando…

Present and Future of Parkinson’s Disease in Spain: PARKINSON-2030 Delphi Project

Parkinson’s disease (PD) is a chronic progressive and irreversible disease and the second most common neurodegenerative disease worldwide. In Spain, it affects around 120.000–150.000 individuals, and its prevalence is estimated to increase in the future. PD has a great impact on patients’ and caregi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos García, Diego, Blázquez-Estrada, Marta, Calopa, Matilde, Escamilla-Sevilla, Francisco, Freire, Eric, García Ruiz, Pedro J., Grandas, Francisco, Kulisevsky, Jaime, López-Manzanares, Lydia, Martínez Castrillo, Juan Carlos, Mir, Pablo, Pagonabarraga, Javier, Pérez-Errazquin, Francisco, Salom, José María, Tijero, Beatriz, Valldeoriola, Francesc, Yáñez, Rosa, Avilés, Arantxa, Luquín, María-Rosario
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393421/ https://www.ncbi.nlm.nih.gov/pubmed/34439646 http://dx.doi.org/10.3390/brainsci11081027

Ejemplares similares

A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

Erratum: Pagonabarraga, J.; et al. A Spanish Consensus on the Use of Safinamide for Parkinson’s Disease in Clinical Practice. Brain Sci. 2020, 10, 176
por: Pagonabarraga, Javier, et al.
Publicado: (2020)

MNCD: A New Tool for Classifying Parkinson’s Disease in Daily Clinical Practice
por: Santos García, Diego, et al.
Publicado: (2021)

Patient and caregiver outcomes with levodopa-carbidopa intestinal gel in advanced Parkinson’s disease
por: Valldeoriola, Francesc, et al.
Publicado: (2021)

Agonistas dopaminérgicos y neuroprotección en la enfermedad de Parkinson /
por: Grandas, Francisco
Publicado: (2003)

Nonmotor Symptoms in LRRK2 G2019S Associated Parkinson’s Disease
por: Gaig, Carles, et al.
Publicado: (2014)

Risk of Falls in Parkinson's Disease: A Cross-Sectional Study of 160 Patients
por: Contreras, Ana, et al.
Publicado: (2012)

Facial Emotion Recognition Impairment in Patients with Parkinson's Disease and Isolated Apathy
por: Martínez-Corral, Mercè, et al.
Publicado: (2010)

Validation study of the Parkinson’s Fatigue Scale in advanced Parkinson’s disease
por: Martinez-Martin, Pablo, et al.
Publicado: (2019)

Early Postural Instability in Parkinson's Disease: A Biomechanical Analysis of the Pull Test
por: Pérez-Sánchez, Javier Ricardo, et al.
Publicado: (2019)

On Disease Modifying and Neuroprotective Treatments for Parkinson's Disease: Physical Exercise
por: Garcia Ruiz, Pedro J., et al.
Publicado: (2022)

Dopamine Dysregulation Syndrome and Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
por: De la Casa-Fages, Beatriz, et al.
Publicado: (2011)

Validation of a simple screening tool for early diagnosis of advanced Parkinson’s disease in daily practice: the CDEPA questionnaire
por: Martinez-Martin, Pablo, et al.
Publicado: (2018)

Tremor Types in Parkinson Disease: A Descriptive Study Using a New Classification
por: Gironell, Alexandre, et al.
Publicado: (2018)

Consensus on the Definition of Advanced Parkinson's Disease: A Neurologists-Based Delphi Study (CEPA Study)
por: Luquin, Maria-Rosario, et al.
Publicado: (2017)

The impact of dopaminergic treatment over cognitive networks in Parkinson's disease: Stemming the tide?
por: Aracil‐Bolaños, Ignacio, et al.
Publicado: (2021)

Pattern of Regional Cortical Thinning Associated with Cognitive Deterioration in Parkinson’s Disease
por: Pagonabarraga, Javier, et al.
Publicado: (2013)

Rotigotine transdermal patch and sleep in Parkinson’s disease: where are we now?
por: Rosa-Grilo, Miguel, et al.
Publicado: (2017)

Psychometric Properties of the Apathy Scale in Advanced Parkinson's Disease
por: Wetmore, John B., et al.
Publicado: (2019)

Staging Parkinson’s Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life
por: Santos-García, Diego, et al.
Publicado: (2023)

Phonetic relevance and phonemic grouping of speech in the automatic detection of Parkinson’s Disease
por: Moro-Velazquez, Laureano, et al.
Publicado: (2019)

Safinamide in the treatment pathway of Parkinson’s Disease: a European Delphi Consensus
por: Stocchi, Fabrizio, et al.
Publicado: (2022)

Prevalence of Advanced Parkinson’s Disease in Patients Treated in the Hospitals of the Spanish National Healthcare System: The PARADISE Study
por: Martínez-Castrillo, Juan Carlos, et al.
Publicado: (2021)

Parkinson's Disease: Impulsivity Does Not Cause Impulse Control Disorders but Boosts Their Severity
por: Marín-Lahoz, Juan, et al.
Publicado: (2018)

Tratamientos complementarios en la enfermedad de Parkinson
por: Kulisevsky, Jaime
Publicado: (2004)

Parkinson's Disease: From Genetics to Clinical Practice
por: Clarimón, Jordi, et al.
Publicado: (2013)

Transdermal Rotigotine Improves Sleep Fragmentation in Parkinson's Disease: Results of the Multicenter, Prospective SLEEP-FRAM Study
por: Pagonabarraga, Javier, et al.
Publicado: (2015)

Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients
por: Spataro, Nino, et al.
Publicado: (2016)

Emergencies and critical issues in Parkinson’s disease
por: Simonet, Cristina, et al.
Publicado: (2020)

Intestinal Levodopa/Carbidopa Infusion as a Therapeutic Option for Unresponsive Freezing of Gait after Deep Brain Stimulation in Parkinson's Disease
por: González-Herrero, Belén, et al.
Publicado: (2020)

Falls Predict Acute Hospitalization in Parkinson’s Disease
por: Santos García, Diego, et al.
Publicado: (2023)

Editorial: Neuroprotection and Disease Modification in Parkinson’s Disease
por: Otero-Losada, Matilde, et al.
Publicado: (2021)

Focus on Depression in Parkinson's Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics
por: Agüera-Ortiz, Luis, et al.
Publicado: (2021)

Pharmacological management of Parkinson’s disease motor symptoms: update and recommendations from an expert
por: Kulisevsky, Jaime
Publicado: (2022)

Transtornos cognitivos y neuropsiquiátricos en la enfermedad de Parkinson /
por: Kulisevsky Bojarski, Jaime
Publicado: (2003)

Gray/White Matter Contrast in Parkinson’s Disease
por: Uribe, Carme, et al.
Publicado: (2018)

A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease
por: Kulisevsky, Jaime, et al.
Publicado: (2022)

Predictors of clinically significant quality of life impairment in Parkinson’s disease
por: Santos García, Diego, et al.
Publicado: (2021)

Identifying comorbidities and lifestyle factors contributing to the cognitive profile of early Parkinson’s disease
por: Martínez-Horta, Saul, et al.
Publicado: (2021)

Discriminating cognitive status in Parkinson’s disease through functional connectomics and machine learning
por: Abós, Alexandra, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_dv3isfch0dkv5qmtig7edandag